Behavioral and Neuroanatomical Characterization of a Novel Genetic Animal Model o
Behavioral and Neuroanatomical Characterization of a Novel Genetic Animal Model o
批准号:
7881342
负责人:
PATRICK John SCHULTHEIS
金额:
$20.31万
依托单位国家:
美国
项目类别:
财政年份:
2010
资助国家:
美国
项目状态:
已结题
起止时间:
2010-02-01 至 2015-01-31
关键词:
ATP phosphohydrolaseAblationAddressAffectAgeAnimal ModelAnimalsAntibodiesAnxietyAtrophicAutophagocytosisBasal GangliaBehaviorBehavioralBehavioral AssayBiological AssayBradykinesiaBrainCaenorhabditis elegansCell CountCell SurvivalCell physiologyChronicClinicalCorpus striatum structureDataDegradation PathwayDevelopmentDiseaseDopamineEnvironmental Risk FactorEquilibriumExhibitsExonsFunctional disorderGaitGenesGeneticGlobus PallidusGlutamate DecarboxylaseHomologous GeneHumanImpaired cognitionInclusion BodiesInheritedIntraperitoneal InjectionsKnockout MiceLeadLearningLewy BodiesLinkMRI ScansManganeseMeasurementMediatingMemoryMental DepressionMotorMovementMusMuscle RigidityMutationNematodaNerve DegenerationNeuroanatomyNeurodegenerative DisordersNeurogliaNeuronsOrthologous GeneOxidative StressPARK9 geneParkinson DiseaseParkinsonian DisordersPathogenesisPatientsPhenotypePhosphorylation SitePlayPredispositionProteinsRattusRelative (related person)ResearchRodentRoleSalineStaining methodStainsSubstantia nigra structureSubstrate SpecificitySymptomsSyndromeTestingToxic effectTremorTyrosine 3-MonooxygenaseYeastsalpha synucleinbehavior testbrain tissuecresyl violetdesigndopaminergic neuronenzyme activityexposed human populationgamma-Aminobutyric Acidimprovedinsightlysosomal proteinsmanganese chloridemorris water mazeneurotoxicneurotoxicitynigrostriatal pathwaynonhuman primatenovelprotein degradationpublic health relevance
中文摘要
点击翻译按钮获取中文摘要
英文摘要
DESCRIPTION (provided by applicant): Mutations in ATP13A2, which encodes a lysosomal P type ATPase, result in KuforRakeb syndrome, an atypical form of Parkinson's disease (PD). Its yeast ortholog, YPK9, has also been shown to protect against a-synuclein and manganese-induced toxicity, established genetic and environmental risk factors for PD, respectively. These observations suggest that ATP13A2 may play an important role in PD pathogenesis, possibly through its influence on lysosomal protein degradation pathways (autophagy) and/or by functioning to sequester manganese, protecting against its neurotoxic effects. We have established an animal model for this rare, familial form of PD by disrupting the Atp13a2 gene in mice. In Aim 1 we will characterize the knockout mice to determine if they exhibit any of the behavioral or neuroanatomical hallmarks of PD such as motor dysfunction and loss of dopaminergic neurons in the nigrostriatal pathway. To achieve this aim wildtype (Atp13a2+/+) and Atp13a2deficient (Atp13a2-/-) mice will be subjected to an array of behavioral assays to assess motor function, learning, and memory and histological analyses to identify alterations in brain neuroanatomy with emphasis placed on the substantia nigra (SN) and globus pallidus (GP), regions known to be affected in sporadic PD and KuforRakeb syndrome, respectively. In Aim 2 we will evaluate the sensitivity of the Atp13a2-/- mice and primary mesencephalic cultures derived from them to manganese, which we anticipate may exacerbate their phenotype relative to controls. Behavioral and histological analyses on mice chronically exposed to manganese will be carried out as described in Aim 1, while cell viability and immunocytochemical assays and measurements of oxidative stress will be performed to assess the sensitivity of neurons in the primary mesencephalic cultures to the toxic effects of manganese. Data obtained from these studies may help establish an important link between genetic and environmental risk factors for PD and improve our understanding of the pathological mechanisms underlying both sporadic and genetic forms of PD.
PUBLIC HEALTH RELEVANCE: Parkinson's disease (PD) is the second most common neurodegenerative disorder. We have created a mouse animal model to research a rare, inherited form of this disease called Kufor- Rakeb syndrome. Our findings could lead to new insights into the causes of PD and its treatment.
期刊论文(1)
专著(0)
科研奖励(0)
会议论文
DOI:
10.1016/j.neuro.2017.06.005
发表时间:
2018-01
期刊:
NEUROTOXICOLOGY
影响因子:
3.4
作者:
[Fleming, Sheila M., Santiago, Nicholas A., Mullin, Elizabeth J., Pamphile, Shanta, Karkare, Swagata, Lemkuhl, Andrew, Ekhator, Osunde R., Linn, Stephen C., Holden, John G., Aga, Diana S., Roth, Jerome A., Liou, Benjamin, Sun, Ying, Shull, Gary E., Schultheis, Patrick J.]
通讯作者:
Schultheis, Patrick J.
BEHAVIORAL, NEUROANATOMICAL CHARACTERIZATION NOVEL GENETIC ANIMAL PARKINSON'S
-
批准号:8360105
-
项目类别:
-
资助金额:$6.39万
-
财政年份:2011
-
负责人:PATRICK John SCHULTHEIS
-
依托单位:
SCHULTHEIS POST-DOC/TECHNICIAN SUPPORT
-
批准号:8168281
-
项目类别:
-
资助金额:$6.45万
-
财政年份:2010
-
负责人:PATRICK John SCHULTHEIS
-
依托单位:
CHARACTERIZATION OF PUTATIVE MAGNESIUM TRANSPORTING P-TYPE ATPASES
-
批准号:7960109
-
项目类别:
-
资助金额:$16.06万
-
财政年份:2009
-
负责人:PATRICK John SCHULTHEIS
-
依托单位:
CHARACTERIZATION OF PUTATIVE MAGNESIUM TRANSPORTING P-TYPE ATPASES
-
批准号:7720133
-
项目类别:
-
资助金额:$15.96万
-
财政年份:2008
-
负责人:PATRICK John SCHULTHEIS
-
依托单位:
CHARACTERIZATION OF PUTATIVE MAGNESIUM TRANSPORTING P-TYPE ATPASES
-
批准号:7610387
-
项目类别:
-
资助金额:$15.54万
-
财政年份:2007
-
负责人:PATRICK John SCHULTHEIS
-
依托单位:
Characterization of the P5 Subfamily of P-type Transport ATPases in Mice
-
批准号:7189750
-
项目类别:
-
资助金额:$19.67万
-
财政年份:2007
-
负责人:PATRICK John SCHULTHEIS
-
依托单位:
CHARACTERIZATION OF PUTATIVE MAGNESIUM TRANSPORTING P-TYPE ATPASES
-
批准号:7381777
-
项目类别:
-
资助金额:$15.51万
-
财政年份:2006
-
负责人:PATRICK John SCHULTHEIS
-
依托单位:
CHARACTERIZATION OF PUTATIVE MAGNESIUM TRANSPORTING P-TYPE ATPASES
-
批准号:7170999
-
项目类别:
-
资助金额:$18.61万
-
财政年份:2005
-
负责人:PATRICK John SCHULTHEIS
-
依托单位:
CHARACTERIZATION OF PUTATIVE MAGNESIUM TRANSPORTING P-TYPE ATPASES
-
批准号:6972565
-
项目类别:
-
资助金额:$7.02万
-
财政年份:2004
-
负责人:PATRICK John SCHULTHEIS
-
依托单位:
Magnesium Deficiency: Global Gene Expression Study
-
批准号:6503795
-
项目类别:
-
资助金额:$12.98万
-
财政年份:2002
-
负责人:PATRICK John SCHULTHEIS
-
依托单位:
海外基金